低分子肝素联合多巴胺治疗新生儿硬肿症的疗效观察

Effective observation on low molecular weight heparin and dopamine in treating neonatal seleredema

目的探讨应用低分子肝素联合多巴胺治疗新生儿硬肿症的临床疗效。方法随机将90例新生儿硬肿症患儿分为对照组和观察组,均予常规治疗,观察组在此基础上加用低分子肝素联合多巴胺治疗,比较两组疗效。结果观察组在硬肿症消退时间及住院总天数方面均优于对照组,差异均有统计学意义(P均<0.05)。结论低分子肝素联合多巴胺治疗新生儿硬肿症效果明显,不良反应小。

Objective To study the effect of low molecular weight heparin and dopamine in treating neonatal selerede- ma. Methods 90 cases of neonatal seleredema were randomly divided into the ontrol group and the observation group. The 2 groups were treated by routine therapy. In addition ,the observation group was added low molecular weight heparin plus dopamine. The efficacies were compared between 2 groups. Results The scleroderma subsided time and hospitalization duration in the ob- servation group were superior to the control group with statistical difference. Conclusion Low molecular weight heparin and dopamine have significant effect with less adverse reactions in treating neonatal seleredema.